| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |